ActiveGRANT

DoW Duchenne Muscular Dystrophy, Idea Development Award

Name: DoW Duchenne Muscular Dystrophy, Idea Development Award
Creator: Department of Defense
Keywords: GRANT

Department of DefenseDept. of the Army -- USAMRAA

AI Overview

Seeking early-stage research to develop novel therapies for Duchenne muscular dystrophy across all age groups, from infants to nonambulatory individuals. High-risk/high-reward studies with strong preliminary data that could accelerate near-term clinical outcomes.

This summary is AI-generated from the official solicitation.

Key Details

Agency

Department of Defense

Funding Amount

—

Release Date

June 17, 2026

Due Date

September 18, 2026

Official Description

<p><strong>Summary: </strong>The fiscal year 2026 (FY26) Duchenne Muscular Dystrophy Research Program (DMDRP) Idea Development Award (IDA) promotes new ideas that are still in the early stages of development and have the potential to yield impactful data and new avenues of investigation. This award supports impactful, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress in improving outcomes for individuals with Duchenne muscu...

View on official source

Change History

Opportunity AddedJun 17, 2026 at 9:06 PM